Dosage unit uniformity and dissolution testing of extended-release pharmaceutical products marketed in the U.S.
2022 · International Journal of Pharmaceutics · 2 citations
https://doi.org/10.1016/j.ijpharm.2022.122119
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
4.0K
Citations
23
h-index
29
i10-index
Richard L. Friedman is an academic researcher from Center for Drug Evaluation and Research. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Ovarian cancer diagnosis and treatment & Bacterial Infections and Vaccines. The author has an h-index of 23, co-authored 35 publications.
Click to start Chat